会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 수신신호코드전력 측정을 위한 적응형 큐 포인트 매핑 방법
    • KR1020100072901A
    • 2010-07-01
    • KR1020080131447
    • 2008-12-22
    • 윤송희
    • 윤송희
    • H04W52/58H04W36/30
    • Y02D70/00
    • PURPOSE: An adaptive Q point mapping method for RSCP measurement is provided to calculate the optimized RSCP(Received Signal Code Power) by using smaller bits. CONSTITUTION: Power of all signals passing through a pulse shaping filter is measured. An RSSI(Received Signal Strength Indicator) is outputted. The number of saturation bits and removal bits is controlled according to the power range proportion to the measured RSSI value. The location of a use bit is changed. The optimized queue point mapping value is applied to the changed use bit. An RSCP is calculated and the calculated RSCP is reported to a base station.
    • 目的:提供用于RSCP测量的自适应Q点映射方法,以通过使用较小的比特来计算优化的RSCP(接收信号码功率)。 规定:测量通过脉冲整形滤波器的所有信号的功率。 输出RSSI(接收信号强度指示符)。 根据与测量的RSSI值成比例的功率范围来控制饱和位数和去除位的数量。 使用位的位置已更改。 优化的队列点映射值应用于已更改的使用位。 计算RSCP,并将计算的RSCP报告给基站。
    • 3. 发明公开
    • 인간화 항체 및 인간화 항체의 제조 방법
    • 人类
    • KR1020100072896A
    • 2010-07-01
    • KR1020080131440
    • 2008-12-22
    • 윤송희
    • 윤송희
    • C07K16/18C07K16/00
    • PURPOSE: A humanized antibody to vascular endothelial growth factor(VEGF) is provided to suppress mitogenic signaling and tumor growth. CONSTITUTION: A humanized antibody to vascular endothelial growth factor(VEGF) is an antibody fragment of Fab, Fab1, F(ab1)2, or Fv. The humanized antibody is manufactured using mutated antibody and phage monovalent surface expressing system. A composition suppressing tumor growth contains the humanized antibody to VEGF. An antigen binding-fragment and remaining "Fc" fragment is prepared by cutting the antibody with papain. The F(ab1)2 fragment is prepared by cutting antibody with a pepsin.
    • 目的:提供血管内皮生长因子(VEGF)的人源化抗体以抑制促有丝分裂信号和肿瘤生长。 构成:血管内皮生长因子(VEGF)的人源化抗体是Fab,Fab1,F(ab1)2或Fv的抗体片段。 使用突变抗体和噬菌体一价表面体系制备人源化抗体。 抑制肿瘤生长的组合含有VEGF的人源化抗体。 通过用木瓜蛋白酶切割抗体来制备抗原结合片段和剩余的“Fc”片段。 通过用胃蛋白酶切割抗体来制备F(ab1)2片段。
    • 4. 发明公开
    • 전지용 비수전해액
    • 电子
    • KR1020100072884A
    • 2010-07-01
    • KR1020080131425
    • 2008-12-22
    • 윤송희
    • 윤송희
    • H01M10/05H01M10/44
    • H01M10/0567H01M10/052H01M10/4235H01M2300/0025Y02E60/122
    • PURPOSE: A non-aqueous electrolyte for a battery is provided to remarkably improve the charge and discharge lifetime property of the battery without reducing low temperature discharge efficiency and charge and discharge efficiency. CONSTITUTION: A non-aqueous electrolyte for a battery is produced by inserting a phenyl sulfone based compound into the non-aqueous electrolyte. The non-aqueous electrolyte is formed with an organic solvent and lithium salt. The organic solvent is a mixture of a cyclic carbonate compound and a chain carbonate compound. Less than 5wt% of phenyl sulfone based compound is included in the non-aqueous electrolyte.
    • 目的:提供一种用于电池的非水电解质,以显着提高电池的充放电寿命特性,而不降低低温放电效率和充放电效率。 构成:通过将苯基砜类化合物插入非水电解液中而制造电池用非水电解质。 非水电解质由有机溶剂和锂盐形成。 有机溶剂是环状碳酸酯化合物和链状碳酸酯化合物的混合物。 非水电解质中含有少于5重量%的苯基砜类化合物。